Visioneering Technologies, Inc. (ASX:VTI)
0.0660
0.00 (0.00%)
Feb 12, 2025, 3:55 PM AEST
Visioneering Technologies Revenue
Visioneering Technologies had revenue of $4.64M USD in the half year ending June 30, 2024, with 24.76% growth. This brings the company's revenue in the last twelve months to $8.64M, up 4.88% year-over-year. In the year 2023, Visioneering Technologies had annual revenue of $8.67M with 19.01% growth.
Revenue (ttm)
$8.64M
Revenue Growth
+4.88%
P/S Ratio
n/a
Revenue / Employee
$191.98K
Employees
45
Market Cap
n/a
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 8.67M | 1.39M | 19.01% |
| Dec 31, 2022 | 7.29M | 131.00K | 1.83% |
| Dec 31, 2021 | 7.15M | 2.05M | 40.14% |
| Dec 31, 2020 | 5.11M | -617.00K | -10.78% |
| Dec 31, 2019 | 5.72M | 2.43M | 73.71% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cochlear | 2.34B |
| PolyNovo | 128.70M |
| SomnoMed | 111.49M |
| Aroa Biosurgery | 79.26M |
| Compumedics | 51.04M |
| Lumos Diagnostics Holdings | 18.91M |
| Micro-X | 13.05M |
| 4DMedical | 5.85M |